REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$65.04
0.00%
(0.00) 1D
Oct 14, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$64.20
High
R$65.04
Low
R$64.20
Mkt. cap
80.14B
Avg. vol.
781.00
Volume
136.00
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
Open
R$64.20
High
R$65.04
Low
R$64.20
Mkt. cap
80.14B
Avg. vol.
781.00
Volume
136.00
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
Trefis
·
5 hours ago
What Could Send Regeneron Stock Higher?
Kalkine Media
·
6 hours ago
Regeneron Pharmaceuticals (NASDAQ:REGN): What Changes After Its Latest Company Update?
Investing.com Canada
·
6 hours ago
Form 144 REGENERON PHARMACEUTICALS For: 14 October By Investing.com
Investor's Business Daily
·
6 hours ago
Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com